Resetting the Immune System: Phase 1 Trial Shows Safety of New MS Therapeutic Approach
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
1. Lutterotti A, Yousef S, Sputtek A, et al. Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis. Science Translational Medicine June 2013; 5(188):188ra75. DOI: 10.1126/scitranslmed.3006168. Accessed at http://stm.sciencemag.org/content/5/188/188ra75 2. Big multiple sclerosis breakthrough: Phase 1 trial safely resets patients' immune systems and reduces attack on myelin protein. Northwestern Press Release. Published June 5, 2013. Accessed at http://www.eurekalert.org/pub_releases/2013-06/nu-bms053113.php 3. “Breakthrough Nanoparticle Halts Multiple Sclerosis: New nanotechnology can be used for Type 1 diabetes, food allergies and asthma” by Marla Paul, Northwestern News. Published November 19, 2012. Accessed at http://www.northwestern.edu/newscenter/stories/2012/11/breakthrough-nanoparticle-halts-multiple-sclerosis.html 4. “Multiple Sclerosis Breakthrough Resets Patients’ Immune Systems” by Jeri Burtchell, HealthlineNews. Published June 5, 2013. Accessed at http://www.healthline.com/health-news/ms-breakthrough-treatment-resets-immune-system-stops-myelin-attacks-060513